Athanese Lavidas, Director at ARIAD PHARMACEUTICALS INC (ARIA), sold 25,000 shares at $16.05 ($401K) on 2012-06-05, disclosed to the SEC on 2012-06-07.
Scheduled sale ($401k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARIA | SELL | 2012-07-23 | $90K | — | Filing → |
| ARIA | SELL | 2012-06-22 | $87K | — | Filing → |
| ARIA | SELL | 2012-05-23 | $83K | — | Filing → |